A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers

Conditions: Healthy Participants Interventions: Biological: Tozorakimab Sponsors: AstraZeneca Not yet recruiting

Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials